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Building BORIS – an outreach project on 
drug design and molecular modelling
Steven Rossington 
(Biomedical Research Centre, 
School of Environment and 
Life Sciences, The University 
of Salford, UK) 
Within university chemistry departments, organic chemists are formulating reaction pathways which 
will yield a desired chemical product. In most cases, it is often found that the targeted product exerts 
some beneficial biological effect towards cellular activity. In my organic chemistry lectureship within 
the University of Salford, I too am involved in the synthesis of potential biologically active compounds; 
namely a range of anti-cancer compounds and anti-bacterial agents. Using my professional knowledge, 
I have developed an outreach project known as BORIS designed to show GCSE and A-level students 
what proteins look like, their importance and role within the body and how drugs interact with them.
proteins in the human body (e.g. the need for protein 
intake in the diet) and the function of enzymes in the body 
(protease, lipase etc.). Additionally, the AS/A2 Biology and 
Chemistry syllabuses also highlighted how proteins are 
formed (transcription and translation), structural identity 
(primary to quaternary structures), functional group 
identification within individual amino acids (amino and 
carboxylic acid portions), how proteins may work, and 
their tasks in the human body (e.g. antibodies, blood 
clotting, Na+/K+ pump in cell membranes etc). It was 
obvious from this that proteins are given great importance 
at both key stage 4 and 5. I envisaged that once a reasonable 
protein model could be constructed, you could highlight 
how any drug system could ‘dock’ into the active site of a 
protein and why some drugs would work on one protein 
but others would not. By re-emphasizing the importance 
of proteins in the development of a disease, a session that 
could showcase the concepts of drug therapy by making it 
‘hands-on and practical’ to the audience could be used to 
highlight the concept of drug therapy whilst supporting 
the appropriate syllabus.
The idea in practice
With the idea of explaining drug therapy by molecular 
modelling in place, work started on building the model 
protein structure. Early on I decided that a simplified 
story of a protein responsible for pain would be told. The 
enzyme cyclooxygenase (COX), found in the human 
body, is responsible for prostaglandin production and 
hence pain transmission. The structure of this enzyme 
is known, but I decided to produce a generic protein 
structure instead. 
With a supply of metal coat hangers and pliers in 
hand, over a period of two months a twisted metal 
structure emerged which satisfied me that what was taking 
shape was a structure resembling the tertiary/quaternary 
structure of a protein. The metal inner skeleton was 
then coated in insulating foam and, after the application 
of a silver tape to give an outer skin, a giant protein 
Research chemists are fully aware that our finalized 
compounds will only show ‘activity’ if they manage 
to interact successfully with the targeted organism. 
Simplistically, any ‘drug’ must target a host protein 
that is contributing to a deleterious effect in order for a 
therapeutic benefit to be felt. Once the structure of this 
protein has been confirmed, computerised molecular 
modelling can enable chemists to identify possible ‘drug’ 
molecules which could target it. With this in mind, 
in the autumn of 2006, I decided to investigate the 
possibility of building a life size protein model which 
could be used to show non-university audiences (namely 
GCSE and A-level students) what proteins look like in 
their fundamental ‘globular shape’, their importance and 
role within the human body and, crucially, how ‘drugs’ 
interact with them when we treat the human body with 
medicinal products.
A quick look at GCSE Biology syllabuses (AQA, 
Edexcel, OCR) revealed content on the importance of 
Figure 1. BORIS at Franklin College in Lincolnshire
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structure had emerged! At this point, when questioned 
by colleagues on what I was up to, I mischievously at 
first responded that I was building a ‘monster’, and on 
the latter stages of constructing the protein, I couldn’t 
get the famous Boris Pickett tune ‘Monster Mash’ of my 
head when I was at work. Hence BORIS (the ‘Biological 
ORIgins of Systems,’ or the ‘Monster’) was born! (figure 
1). Once the giant structure of the model had been built, 
a selection of Molymod (Spring Enterprise Ltd) was 
purchased and ibuprofen, aspirin and paracetamol were 
selected as systems which would be active on ‘BORIS’, a 
protein responsible for the signalling of pain in the body.
For simplicity three ‘active sites’ were constructed on 
the protein and the drug systems would be ‘active’ if two 
criteria were fully met: 
1. The drug model must fit into the ‘active site’.
2.  If the model fits in then certain atom colours 
must match up: black on the active site to black on the 
molecule (black being carbon), red to red (oxygen), blue 
to blue (nitrogen). With this, the idea was to illustrate to 
students the concepts of Lipinski’s rule in a visual way.
Thus, with much patience and care, three carefully 
colour coded active sites were grafted onto ‘Boris’, with 
one site being able to accept ibuprofen, aspirin and 
paracetamol each. Other molecules built, included 
cholesterol, oestrogen, progesterone, testosterone, 
α-glucose, adrenalin, dopamine, serotonin, glycerol, 
adenosine triphosphate, nicotine, caffeine, acetylcholine, 
saccharin, lactic acid, ecstasy, lactic acid, urea, penicillin 
G, Viagra and mustard gas. 
Finding the money and developing the idea
Since 2007, funding has been provided by The 
Biotechnology and Biological Sciences Research 
Council (BBSRC), the Research Council UK (RCUK), 
the Biochemical Society’s Scientific Outreach Grant 
Programme and The Royal Society of Chemistry’s 
Outreach Grant Programme. This funding covered the 
cost of transportation to venues, chemicals for laboratory 
practical sessions and the purchase of Molymod for the 
construction of molecules.
Running events
Two types of presentation were developed, one aimed at 
A-level students and one for GCSE students, and can be 
modified as appropriate. Sessions have been run either 
at the University of Salford or held at the hosting school/
college. On average, fifteen to twenty sessions are held per 
school year and each session can host up to 25 students. 
The session starts with introductions and the aims of the 
session. Questions are then posed to the student-body, 
testing their knowledge, and a PowerPoint presentation 
is delivered which illustrates the importance of cell 
physiology, including; how DNA and proteins are related, how proteins could be responsible 
for transmission and signalling in the human body and the issues of pharmacokinetics 
and pharmacodynamics in drug design. Issues of absorption, distribution, metabolism 
and excretion (ADME) are then brought into the presentation. Once proteins have been 
introduced, depending on the age and level of the audience, then ‘molecular shape’, drug 
shape and chirality of molecules are explained, together with examples of chiral molecules 
in nature. The presentation then recaps why some chiral molecules may exert biological 
effect and some may not. For all audiences, the example of the drug Thalidomide is used 
to explain why we always need to get the correct ‘3D-shape’ of a molecule and what could 
happen if the wrong ‘shape’ of a drug is introduced into the body. 
An experimental session was also incorporated, namely an electrophoresis practical if 
the session is run over a suitable period of time. A practical of thin layer chromatography 
and chromatography of amino acids or common organic molecules also took place. In 
addition to the laboratory session, in the past two years a computing molecular modelling 
session using AutoDock Vina has also been incorporated into the session. 
Identification of audiences and future plans
This project has, to date, worked with schools and colleges and members of the public 
(Rotary Clubs, Manchester and Bradford Science Festivals) throughout the UK. Since 
2007, over 156 secondary schools, colleges and academies have been engaged with 
records showing 6942 students and 213 teachers have taken in events. Schools and 
colleges are contacted by myself or by the university for ‘taster sessions’. I believe future 
activities will benefit from the inclusion of more Molymod molecule construction, 
using more computer modelling in sessions as the provision of internet-use in lessons 
is increasing with greater access to 4G/5G networks, and, for those schools and colleges 
wishing to receive them, the inclusion of the laboratory sessions. Any interested school/
college interested in receiving a visit is encouraged to contact me (S.B.Rossington@
salford.ac.uk) for more details.  ■
Figure 2. Molecular modelling using AutoDock Vina at Runshaw College in Lancashire.
If you’re interested in running your own public engagement event on protein-drug 
interactions, why not try downloading the Biochemical Society’s Medicine Makers activity, 
available on our website.
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